News
The Niemann-Pick Foundation donates nearly 105,000 euros to continue with the clinical trial of a drug to stop the disease-related cognitive deterioration
Dr. Gascón thanked the tireless effort of the Niemann-Pick Foundation to
promote research as a tool to improve patients' quality of life.
Efavirenz is an antiretroviral drug used in HIV treatment that improves the
function of an enzyme that regulates cholesterol.
A new study carried out in Bellvitge warns about the bone mass loss after bariatric surgery
A new study by IDIBELL and Bellvitge University Hospital, published in the journal Bone, reveals that some bariatric surgeries can have an impact on bone health, especially in the hip area.
BioCluster, gamification and innovation in health: IDIBELL’s participation in the Smart City Expo World Congress 2024
The Innovation and Health Biocluster presents itself as a key alliance to position L’Hospitalet in research and advanced medicine.
Establishing safe nursing coverage can prevent complications with the peripheral venous catheter, according to two new GRIN-IDIBELL publications
Two recent studies led by the GRIN-IDIBELL Nursing Research Group show the impact of the number of nurses and the complexity of care on complications associated with the peripheral venous catheter of patients treated in hospitalization and emergencies.
Researchers identify 6 genetic regions that could reduce cardiovascular risk
Researchers from five Catalan research centres have collaborated on a large-scale genetic study in search of new biomarkers and therapeutic targets that could reduce cardiovascular risk by modulating blood metabolites.
Sara Calvo receives the award for the best health research article for doctoral students at the 15th ICS Conference
Maria Molina, scientific director of IDIBELL, moderated the round table on the research career at the ICS.
Scientists identify biomarkers in semen samples that could help reduce overdiagnosis in prostate cancer screening
IDIBELL researchers have led the discovery of biomarkers that could improve the non-invasive detection of clinically relevant prostate cancer cases.
A study published in JAMA shows the good results of a new extracorporeal blood purification membrane
The results of the SIRAKI02 study show that the use of a new extracorporeal blood purification membrane reduces acute kidney failure after complex cardiac surgery.
Promising preclinical results against lung cancer with innovative strategies to combat resistance
Two studies reveal new therapeutic approaches for lung cancer patients with BRAFV600E and KRASG12C mutations. The advanced preclinical models generated by IDIBELL and ICO professionals have been essential for this research.